360 related articles for article (PubMed ID: 33214235)
1. Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature.
Abeles RD; Foxton M; Khan S; Goldin R; Smith B; Thursz MR; Verma S
BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33214235
[TBL] [Abstract][Full Text] [Related]
2. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
Teschke R; Méndez-Sánchez N; Eickhoff A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
[TBL] [Abstract][Full Text] [Related]
3. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
Teschke R; Danan G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
[TBL] [Abstract][Full Text] [Related]
4. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
Danan G; Teschke R
Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
[TBL] [Abstract][Full Text] [Related]
5. Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview.
Teschke R; Eickhoff A; Schulze J; Danan G
Transl Gastroenterol Hepatol; 2021; 6():51. PubMed ID: 34423172
[TBL] [Abstract][Full Text] [Related]
6. Versatility of Anabolic Androgenic Steroid-Induced Hepatotoxicity.
Patil V; Jothimani D; Harika K; Hakeem AR; Sachan D; Vij M; Rela M
J Clin Exp Hepatol; 2022; 12(1):216-221. PubMed ID: 35068803
[TBL] [Abstract][Full Text] [Related]
7. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM).
Teschke R; Danan G
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33800917
[TBL] [Abstract][Full Text] [Related]
8. Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature.
Studentova H; Volakova J; Spisarova M; Zemankova A; Aiglova K; Szotkowski T; Melichar B
BMC Gastroenterol; 2022 Feb; 22(1):49. PubMed ID: 35123392
[TBL] [Abstract][Full Text] [Related]
9. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
Teschke R
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
[TBL] [Abstract][Full Text] [Related]
10. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
Teschke R; Schulze J; Eickhoff A; Danan G
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
[TBL] [Abstract][Full Text] [Related]
11. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.
Das S; Behera SK; Xavier AS; Velupula S; Dkhar SA; Selvarajan S
Clin Drug Investig; 2018 Mar; 38(3):211-218. PubMed ID: 29185238
[TBL] [Abstract][Full Text] [Related]
12. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study.
Rodríguez A; García-García I; Martínez de Soto L; Gómez López De Las Huertas A; Borobia AM; González-Torbay A; Akatbach-Bousaid I; González-Muñoz M; Ramírez E
Front Pharmacol; 2022; 13():819589. PubMed ID: 35370653
[No Abstract] [Full Text] [Related]
13. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).
Shumar J; Ordway S; Junga Z; Sadowski B; Torres D
ACG Case Rep J; 2019 Aug; 6(8):e00184. PubMed ID: 31737715
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced liver injury from selective androgen receptor modulators, anabolic-androgenic steroids and bodybuilding supplements in Australia.
Nash E; Nicoll A; Batt N; George J; Perananthan V; Prince D; Wallace M; Gow P; Vaz K; Chitturi S; Flores JE; Braund A; Bonnichsen M; Riordan S; Humphris J; Duong T; McKenzie C; Liu K; Strasser SI
Aliment Pharmacol Ther; 2024 Apr; 59(8):953-961. PubMed ID: 38372012
[TBL] [Abstract][Full Text] [Related]
15. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids.
Robles-Diaz M; Gonzalez-Jimenez A; Medina-Caliz I; Stephens C; García-Cortes M; García-Muñoz B; Ortega-Alonso A; Blanco-Reina E; Gonzalez-Grande R; Jimenez-Perez M; Rendón P; Navarro JM; Gines P; Prieto M; Garcia-Eliz M; Bessone F; Brahm JR; Paraná R; Lucena MI; Andrade RJ; ;
Aliment Pharmacol Ther; 2015 Jan; 41(1):116-25. PubMed ID: 25394890
[TBL] [Abstract][Full Text] [Related]
16. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis.
Teschke R; Danan G
Medicines (Basel); 2020 Sep; 7(10):. PubMed ID: 33003400
[No Abstract] [Full Text] [Related]
17. Drug-Induced Liver Injury during Consolidation Therapy in Childhood Acute Lymphoblastic Leukemia as Assessed for Causality Using the Updated RUCAM.
Qin FL; Sang GY; Zou XQ; Cheng DH
Can J Gastroenterol Hepatol; 2022; 2022():5914593. PubMed ID: 35369115
[TBL] [Abstract][Full Text] [Related]
18. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019.
Teschke R
Front Pharmacol; 2019; 10():730. PubMed ID: 31396080
[TBL] [Abstract][Full Text] [Related]
19. Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method.
Ye L; Feng Z; Huang L; Guo C; Wu X; He L; Tan W; Wang Y; Wu X; Hu B; Li T; Yang G; Chengxian G; He Q
Front Pharmacol; 2021; 12():790108. PubMed ID: 34987403
[No Abstract] [Full Text] [Related]
20. An analysis of silybin meglumine tablets in the treatment of drug-induced liver injury as assessed for causality with the updated Roussel Uclaf Causality Assessment Method using a nationwide database.
Zhang B; Jiang G; Wang L; Li X; Zhao C; Tan Q; Kang W; Feng Y; Han X; Raza HK; Mao Y
Br J Clin Pharmacol; 2023 Apr; 89(4):1329-1337. PubMed ID: 36278948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
